Logotype for EverCommerce Inc

EverCommerce (EVCM) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for EverCommerce Inc

Q3 2025 earnings summary

9 Jul, 2026

Executive summary

  • Q3 2025 revenue grew 5.3% year-over-year to $147.5 million, within guidance, driven by recurring subscription and transaction fees and expansion in core verticals.

  • Adjusted EBITDA reached $46.5 million, representing a 31.5% margin, up 140 basis points year-over-year and exceeding guidance.

  • Net income turned positive, with $11.1 million reported for Q3 2025, reversing prior year losses.

  • Strategic focus sharpened by the sale of marketing technology solutions and the acquisition of ZyraTalk, an AI-powered agentic platform, to accelerate AI integration.

  • Over 725,000 customers served across three verticals, with EverPro and EverHealth accounting for 95% of revenue.

Financial highlights

  • Subscription and transaction revenue was $142.2 million, with core SaaS revenue growing over 8% year-over-year.

  • Adjusted gross profit was $114 million, with a margin of 77.3%.

  • Payments revenue grew 6% year-over-year, now 21% of total revenue, and reported on a net basis with 95% gross margin.

  • Free cash flow from operations was $32.5 million for the quarter, up from $27.5 million in Q3 2024.

  • Net income for Q3 2025 was $11.1 million, compared to a net loss of $9.2 million in Q3 2024.

Outlook and guidance

  • Q4 2025 revenue expected between $148 million and $152 million; Adjusted EBITDA between $39.5 million and $41.5 million.

  • Full-year 2025 revenue guidance narrowed to $584 million–$592 million; Adjusted EBITDA to $174.5 million–$179.5 million, with an increase at the top end.

  • Guidance reflects continued operations, excludes divested marketing tech, and includes ZyraTalk with immaterial Q4 impact.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more